Leticia Lopes Quirino Pantoja1, Isabela Porto de Toledo2,3, Yasmine Mendes Pupo4, André Luís Porporatti3,5, Graziela De Luca Canto3,5,6, Liete Figueiredo Zwir7, Eliete Neves Silva Guerra8. 1. Laboratory of Oral Histopathology, Health Sciences Faculty, University of Brasília, SHIS QL 18 conjunto 07 casa 01, Brasília, DF, Brazil. lqpantoja@gmail.com. 2. Laboratory of Oral Histopathology, Health Sciences Faculty, University of Brasília, SHIS QL 18 conjunto 07 casa 01, Brasília, DF, Brazil. 3. Brazilian Centre for Evidence Based Research, Department of Dentistry, Federal University of Santa Catarina, Florianopolis, SC, Brazil. 4. Department of Restorative Dentistry, Federal University of Parana, Curitiba, PR, Brazil. 5. Department of Dentistry, Federal University of Santa Catarina, Florianopolis, SC, Brazil. 6. School of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. 7. Department of Dentistry, Federal University of Sao Paulo, São Paulo, SP, Brazil. 8. Laboratory of Oral Histopathology, Health Sciences Faculty, University of Brasília, Brasília, Brazil.
Abstract
OBJECTIVES: The purpose of this systematic review was to evaluate evidence about the prevalence of degenerative joint disease (DJD) of the temporomandibular joints (TMJ). MATERIALS AND METHODS: We performed search on electronic databases and gray literature from their inception to January 2018. Studies reporting prevalence data of DJD on TMJ were included. DJD was assessed through clinical and imaging diagnosis. Studies risk of bias was evaluated using the Critical Appraisal Checklist for Studies Reporting Prevalence Data. RESULTS: From 1082 studies, 32 were identified, and the sample size included 3435 subjects. They were clustered into two groups: the first comprised studies that reported prevalence of DJD in TMJ secondary to rheumatic systemic diseases like juvenile idiopathic arthritis (JIA) and rheumatoid arthritis (RA) and the second group comprised studies that reported prevalence of DJD on temporomandibular disorder patients. The prevalence of DJD on JIA patients ranged from 40.42% (n = 47) to 93.33% (n = 15) and on RA patients from 45.00% (n = 20) to 92.85% (n = 56). Among TMD patients, the prevalence of DJD reported according to patients ranged from 18.01% (n = 1038) to 84.74% (n = 118) and reported according to joints ranged from 17.97% (n = 178) to 77.23% (n = 224). CONCLUSION: This review attempts to high prevalence of DJD in patients with systemic rheumatic disease and a less prevalent, but still high, occurrence in patients with TMD without systemic involvement. CLINICAL RELEVANCE: Specialist doctors and dentists should be alert to not underestimate and to correctly diagnose DJD of the TMJ early in patients with rheumatic disease and TMD.
OBJECTIVES: The purpose of this systematic review was to evaluate evidence about the prevalence of degenerative joint disease (DJD) of the temporomandibular joints (TMJ). MATERIALS AND METHODS: We performed search on electronic databases and gray literature from their inception to January 2018. Studies reporting prevalence data of DJD on TMJ were included. DJD was assessed through clinical and imaging diagnosis. Studies risk of bias was evaluated using the Critical Appraisal Checklist for Studies Reporting Prevalence Data. RESULTS: From 1082 studies, 32 were identified, and the sample size included 3435 subjects. They were clustered into two groups: the first comprised studies that reported prevalence of DJD in TMJ secondary to rheumatic systemic diseases like juvenile idiopathic arthritis (JIA) and rheumatoid arthritis (RA) and the second group comprised studies that reported prevalence of DJD on temporomandibular disorderpatients. The prevalence of DJD on JIA patients ranged from 40.42% (n = 47) to 93.33% (n = 15) and on RApatients from 45.00% (n = 20) to 92.85% (n = 56). Among TMDpatients, the prevalence of DJD reported according to patients ranged from 18.01% (n = 1038) to 84.74% (n = 118) and reported according to joints ranged from 17.97% (n = 178) to 77.23% (n = 224). CONCLUSION: This review attempts to high prevalence of DJD in patients with systemic rheumatic disease and a less prevalent, but still high, occurrence in patients with TMD without systemic involvement. CLINICAL RELEVANCE: Specialist doctors and dentists should be alert to not underestimate and to correctly diagnose DJD of the TMJ early in patients with rheumatic disease and TMD.
Authors: Priscila Brenner Hilgenberg-Sydney; Luís Felipe Schenato; Helena Bussular Marques; Fernanda Mara de Paiva Bertoli; Daniel Bonotto Journal: Oral Radiol Date: 2021-05-24 Impact factor: 1.852
Authors: Christopher Schmidt; Taila Ertel; Martin Arbogast; Boris Hügle; Thekla von Kalle; Andreas Neff Journal: Dtsch Arztebl Int Date: 2022-01-28 Impact factor: 8.251
Authors: Pieter-Jan Verhelst; Fréderic Van der Cruyssen; Antoon De Laat; Reinhilde Jacobs; Constantinus Politis Journal: Front Physiol Date: 2019-08-07 Impact factor: 4.566
Authors: Marit S Skeie; Elisabeth G Gil; Lena Cetrelli; Annika Rosén; Johannes Fischer; Anne Nordrehaug Åstrøm; Keijo Luukko; Xieqi Shi; Astrid J Feuerherm; Abhijit Sen; Paula Frid; Marite Rygg; Athanasia Bletsa Journal: BMC Oral Health Date: 2019-12-19 Impact factor: 2.757